Merck loses bid to revive over Rs 18 crore patent verdict against Gilead Farhat Nasim31 Oct 2019 3:27 PM ISTIn 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 9:30 AM ISTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict Ruby Khatun Khatun19 Feb 2018 9:45 AM ISTA federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
Merck to stop development of hepatitis C treatments Ruby Khatun Khatun4 Oct 2017 10:20 AM ISTU.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...